Evommune, Inc. Balance Sheet
Evommune, Inc.'s total assets for Q4 2025 were $224.95M, an increase of 166.07% from the previous quarter. EVMN total liabilities were $19.38M for the fiscal quarter, a -92.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.